You are here

  • Home
  • Archive
  • Volume 15, Issue 2
  • Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169 572 per QALY and exenatide with $278 935 per QALY as second-line treatment in adult diabetics in the USA

Article metrics

Article menu
Download PDFPDF
Therapeutics
Cost-effectiveness analysis
Compared with glyburide, sitagliptin associated with incremental cost-effectiveness ratio of $169 572 per QALY and exenatide with $278 935 per QALY as second-line treatment in adult diabetics in the USA

 

Online download statistics by month:

Online download statistics by month: May 2010 to March 2024

AbstractFullPdf
May 201011217277
Jun 2010391920
Jul 201028149
Aug 201026108
Sep 201017189
Oct 2010181610
Nov 201015208
Dec 2010161414
Jan 2011132115
Feb 201130136
Mar 201120118
Apr 201123116
May 20115035
Jun 20113636
Jul 20116357
Aug 20115449
Sep 201123610
Oct 20113224
Nov 20114355
Dec 20112646
Jan 20121859
Feb 20121502
Mar 20122702
Apr 20121077
May 20121663
Jun 2012756
Jul 20121600
Aug 2012722
Sep 20122334
Oct 20123174
Nov 2012066
Dec 2012054
Jan 2013034
Feb 2013013
Mar 2013012
Apr 2013052
May 2013021
Jun 20132203
Jul 20131332
Aug 20131001
Sep 20131201
Oct 20131102
Nov 20132235
Dec 20132121
Jan 20141323
Feb 20142132
Mar 20142333
Apr 20142665
May 20141221
Jun 20141532
Jul 20143004
Aug 20141432
Sep 20142131
Oct 20142711
Nov 20141800
Dec 20141401
Jan 20152355
Feb 20151100
Mar 20151833
Apr 20151002
May 20151511
Jun 2015401
Jul 20151500
Aug 20151600
Sep 2015900
Oct 2015410
Nov 20151512
Dec 20152712
Jan 20162221
Feb 2016710
Mar 2016423
Apr 20162623
May 20162311
Jun 2016600
Jul 20161100
Aug 2016700
Sep 20161411
Oct 201612534
Nov 20161000
Dec 20161000
Jan 20171800
Feb 20171000
Mar 20171521
Apr 20171921
May 20171100
Jun 20172422
Jul 20172711
Aug 20173000
Sep 20173200
Oct 20172111
Nov 20173811
Dec 20173700
Jan 20183800
Feb 20183911
Mar 20182310
Apr 20185010
May 20184421
Jun 20189000
Jul 20182732
Aug 20182000
Sep 20182800
Oct 20183600
Nov 20184011
Dec 20184143
Jan 20193000
Feb 20195522
Mar 20195920
Apr 20192900
May 20193001
Jun 20192701
Jul 20194521
Aug 20195401
Sep 20192511
Oct 20193010
Nov 20191001
Dec 20192110
Jan 20201510
Feb 20201400
Mar 2020421
Apr 20201313
May 20203200
Jun 20201301
Jul 20201421
Aug 20202904
Sep 20202200
Oct 20201200
Nov 20202001
Dec 20201900
Jan 20212201
Feb 20211911
Mar 20212011
Apr 20212851
May 2021311
Jul 2021111
Aug 2021220
Sep 2021110
Oct 20212812
Nov 20212511
Dec 20214702
Jan 20221320
Feb 20222900
Mar 20224200
Apr 20223800
May 20225800
Jun 20223200
Jul 20223200
Aug 20225311
Sep 20223700
Oct 20224111
Nov 20221800
Dec 20222100
Jan 2023500
Feb 20235900
Mar 2023601
Apr 20231600
May 20231800
Jun 20231500
Jul 20232000
Aug 2023500
Sep 2023710
Oct 20232002
Nov 20231911
Dec 20233600
Jan 20241121
Feb 20241100
Mar 20242300
Total3892546424